Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,000 | 0 | 0 | -1 | 122 |
| Gross Profit | 1,000 | N/A | N/A | -1 | 122 |
| Operating Expenses | 17,758 | 23,098 | 25,525 | 33,022 | 29,865 |
| Operating Income | -16,758 | -23,098 | -25,525 | -33,023 | -29,743 |
| Other Income | -2,232 | 1,768 | 3,700 | 77,030 | -38,848 |
| Pre-tax Income | -18,990 | -21,330 | -21,825 | 44,007 | -68,591 |
| Net Income Continuous | -18,990 | -21,330 | -21,825 | 44,007 | -68,591 |
| Net Income | $-18,990 | $-21,330 | $-21,825 | $44,007 | $-68,591 |
| EPS Basic Total Ops | -0.13 | -0.15 | -0.15 | 0.37 | -0.48 |
| EPS Basic Continuous Ops | -0.13 | -0.15 | -0.15 | 0.37 | -0.48 |
| EPS Diluted Total Ops | -0.13 | -0.15 | -0.15 | 0.52 | -0.48 |
| EPS Diluted Continuous Ops | -0.13 | -0.15 | -0.15 | 0.37 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.15 | -0.15 | -0.24 | -0.20 |
| EBITDA(a) | $-16,647 | $-22,988 | $-25,421 | $-32,943 | $-29,639 |